Replay available

Teladoc Health, Inc. (TDOC) Q4 2025 Earnings Call

Teladoc Health, Inc. (NYSE: TDOC) Q4 2025 earnings conference call, held 2026-02-25. Replay captured from the company's public earnings webcast.

Wed, February 25, 2026 at 5:00 PMendedReplay
Teladoc Health, Inc. (TDOC) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Michael Minchak

Head of Investor Relations

Chuck DeVita

Chief Executive Officer

Replay transcript excerpt

Good afternoon, thank you for attending today's Teladoc Health Q4 2025 earnings conference call. My name is Tamia and I will be your moderator for today's call. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. If you would like to ask a question, please press star 1 on your telephone keypad. I would now like to pass the conference over to your host, Michael Minchak, Head of Investor Relations. Please proceed. Press release announcing our fourth quarter 2025 financial results. This press release and the accompanying slide presentation are available in the investor relations section of the TeladocHealth.com website. On the call to discuss the results will be Chuck DeVita, Chief Executive Officer. During this call, we will also discuss our outlook and our prepared remarks will be followed by a question and answer session. Please note that we will be discussing certain non-GAAP financial measures that we believe are important in evaluating our performance. Details on the relationship between these non-GAAP measures to the most comparable GAAP measures and reconciliations thereof can be found in the press release that is posted on our website. Also, please note that certain statements made during this call will be forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, uncertainties, and other factors that could cause our actual results to differ materially from those expressed or implied on this call. For additional information, please refer to our cautionary statement in our press release and our filings with the SEC, all of which are available on our website. I would now like to turn the call over to C...

More from Teladoc Health, Inc.